Sen. Richard J. Durbin

Maddy summaryThe Agency Stability Restoration Act of 2024 amends two federal laws to clarify the timeframe for challenging agency decisions in court. It adds a 6-year statute of limitations for lawsuits under Section 702 of Title 5 (which governs judicial review of agency actions), requiring such cases to be filed within 6 years of the final agency decision. This change affects individuals, businesses, or organizations seeking to legally contest federal agency actions. The bill does not alter substantive agency powers but standardizes the deadline for judicial review under existing law.

Maddy summaryS 412, the SHIELD Act of 2023, creates a federal criminal offense for knowingly distributing non-consensual intimate visual depictions (such as photos or videos of someone without their consent) or visual depictions of nude minors. It directly affects individuals who distribute such content without consent, including those sharing intimate images of adults or nude photos of minors, with penalties including up to 5 years in prison and asset forfeiture. Key provisions define "intimate visual depictions" (showing genitals or engaging in sexual conduct without consent), exclude law enforcement activities and legal reporting from the ban, and require forfeiture of materials used to distribute such content. The bill aims to address non-consensual image sharing and child sexual abuse material through federal criminal penalties.

Maddy summaryThe Affordable Prescriptions for Patients Act of 2023 targets "product hopping" by pharmaceutical manufacturers, which occurs when companies discontinue an original drug to make way for a follow-on product and prevent competition from cheaper generics or biosimilars. The bill prohibits two types of anti-competitive conduct: "hard switches" (discontinuing a drug or withdrawing approval) and "soft switches" (taking actions to disadvantage the original drug relative to a follow-on product). It gives the Federal Trade Commission authority to enforce these rules, including seeking remedies like disgorgement of profits from anti-competitive behavior. This legislation directly affects drug manufacturers, particularly those producing reference drugs and follow-on products, with the goal of increasing competition in the pharmaceutical market and lowering prescription costs.

Maddy summarySRES 765 is a Senate resolution honoring the late Senator James M. Inhofe of Oklahoma following his death on July 9, 2024. The resolution commemorates his 28-year Senate service (1994-2023) and 52 years in public office, highlighting his work on defense policy, aviation legislation, infrastructure projects, and support for military bases in Oklahoma. This procedural resolution expresses the Senate's condolences and formally recognizes his legacy, rather than enacting any policy changes.

Maddy summarySRES 767 is a ceremonial resolution honoring the 175th anniversary of U.S.-Guatemala diplomatic relations, marked on January 31, 2024. It recognizes shared values like democracy, human rights, and economic cooperation, including Guatemala’s role as a major U.S. trading partner and the contributions of Guatemalan-Americans. The resolution also pays tribute to Ambassador Francisco Villagrán de León and acknowledges ongoing collaboration on migration, anti-corruption efforts, and Guatemala’s support for Taiwan. While it includes non-binding statements urging continued partnership on issues like indigenous rights and corruption, it does not create new laws or funding. This is purely a symbolic gesture to mark the anniversary and reaffirm bilateral ties.

Maddy summaryThis bill, S 4691 (No Tax Breaks for Drug Ads Act), removes a tax deduction for pharmaceutical companies that spend on direct-to-consumer advertising of prescription drugs. It directly affects drug manufacturers by eliminating the ability to deduct expenses for ads targeting the general public through TV, radio, print, online, or social media platforms. The key provision prohibits tax deductions for all such advertising costs starting after the bill's enactment date, without changing advertising rules or banning ads. This is a concrete tax policy change affecting pharmaceutical industry spending, not a regulatory measure.

Maddy summaryS 4701 (POST Act of 2024) amends the Higher Education Act to tighten the "85/15 rule" for for-profit colleges receiving federal student aid. It requires these institutions to derive at least 15% of their revenue from non-federal sources, defining precisely which income counts (like tuition, campus-based student activities, or non-federal job training contracts) and which does not (such as book sales, certain federal funds, or income share agreements without clear terms). The bill also mandates annual reports to Congress detailing each institution’s revenue sources. This directly affects for-profit colleges seeking federal student aid eligibility under Title IV, with failure to comply risking loss of aid for at least two years.

Maddy summaryThe Federal Firearm Licensee Act would significantly strengthen regulations for federally licensed firearm dealers, manufacturers, and importers. Key provisions require dealers to implement physical security plans for their premises, conduct regular inventory checks of firearms, and maintain electronic records of all firearm transactions. The bill repeals restrictions that limited law enforcement's access to crime firearm trace data and increases penalties for violations, including civil fines and license suspensions. It also mandates background checks for dealer employees and expands reporting requirements for multiple firearm sales. This legislation directly affects all federally licensed firearm businesses operating under Chapter 44 of Title 18.

Maddy summaryThis bill (S 4554) is a non-binding resolution expressing Congress's "sense" that protections for abortion access should be supported after the *Dobbs* decision and that *Roe v. Wade* protections should be restored. It does not create new laws or change existing policies; it is solely a statement of congressional opinion. The resolution directly affects no individuals or entities, as it lacks legal force. Key provisions (Section 2) state Congress supports post-*Dobbs* reproductive health care access and aims to restore *Roe*-era protections, but these are declarative statements only.

Maddy summarySRES 759 is a non-binding Senate resolution expressing U.S. support for the alliance with Estonia, Latvia, and Lithuania (the Baltic States) amid Russian aggression. It reaffirms U.S. commitment to Baltic security through NATO, supports continued security assistance including the Baltic Security Initiative, and recognizes the Baltic States' contributions to transatlantic defense despite facing Russian intimidation, cyberattacks, and disinformation. The resolution directly affects U.S.-Baltic security cooperation by formally endorsing ongoing military aid and joint defense efforts. It does not create new policy but serves as a symbolic statement of congressional support.